EUVIMEDEUVIMED entdecken
Crossref

Updated endometrial cancer FIGO staging: the role of MRI in determining newly included histopathological criteria

Ahmet Akçay iD, Mehmet Ali Gültekin, Fazılhan Altıntaş, Abdusselim Adil Peker, Serdar Balsak, Bahar Atasoy, Özlem Toluk, Hüseyin Toprak

Abdominal Radiology · 05.06.2024 · 49 (10) · 3711-3721

DOI: 10.1007/s00261-024-04398-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Abdominal Radiology, online erschienen am 05.06.2024. Verfasst von Ahmet Akçay und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Faculty of Medicine, Bezmialem Vakif University, +34093, Istanbul, Turkey. ahmetakcaymd@gmail.com. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Neoplasm Staging, Magnetic Resonance Imaging. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Endometrial cancer (EC) is among the prevalent malignancies in gynecology, showing an increasing occurrence and mortality rate. The updated 2023 FIGO staging integrates both histopathological and molecular analyses, which significantly impact the prognosis and treatment approaches. This research aims to examine the effectiveness of MRI in identifying essential histopathological tumor features, including histological subtype, grade, and lymphovascular space invasion. METHODS: A total of 106 patients diagnosed with EC from February 2018 to December 2023 underwent preoperative pelvic MRI. Surgical procedures followed ESMO guidelines, with histopathological assessments using FIGO 2009 criteria. Two radiologists independently evaluated MRI images, measuring maximum tumor size, minimum tumor ADC value (using a free-hand ROI technique), and ADC tumor/myometrium ratio. MRI findings were compared with histopathological data. RESULTS: Peritoneal implant presence and tumor size exhibited significant differences between endometrioid adenocarcinoma (EAC) and non-endometrioid endometrial carcinoma (NEEC), with p values of < 0.001 and 0.003, respectively. Significant differences in age, tumor size, ADC tumor, and ADC tumor/myometrium between low-grade and high-grade tumors were observed, with p values of < 0.001, 0.004, 0.006, and 0.011, respectively. Increased tumor size, reduced ADC tumor, ADC tumor/myometrium, and pelvic peritoneal implant presence were significantly associated with LVSI, with p values of < 0.001, 0.001, 0.002, and 0.001, respectively. The AUC values for tumor size, ADC tumor, and ADC tumor/myometrium were 0.842, 0.781 and 0.747, respectively, in distinguishing between low and high-grade endometrial tumors. Similarly, obtained AUC values for predicting LVSI were 0.836, 0.719, and 0.696, respectively. CONCLUSION: Our study emphasizes MRI's role in predicting tumor characteristics such as histological subtype, grade, and LVSI based on updated FIGO criteria. By highlighting the potential of MRI, this research contributes to our comprehension of improving diagnostic and clinical management for EC. Further multicenter studies are warranted to validate these findings and establish MRI's role in EC management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsNeoplasm StagingMagnetic Resonance ImagingHumansFemaleMiddle AgedAgedAdultRetrospective StudiesNeoplasm GradingAged, 80 and over

Stichwörter der Autor:innen

Endometrial cancerFIGO classificationLymphovascular space invasionMRITumor gradeTumor subtype

Autor:innen und Institutionen

  • Department of Radiology, Faculty of Medicine, Bezmialem Vakif University, +34093, Istanbul, Turkey. ahmetakcaymd@gmail.com.
  • Department of Radiology, Faculty of Medicine, Bezmialem Vakif University, +34093, Istanbul, Turkey.
  • Department of Biostatistics, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.

ORCID-Profile: Ahmet Akçay

Zitieren

APA

Akçay, A., Gültekin, M. A., Altıntaş, F., Peker, A. A., Balsak, S., Atasoy, B., Toluk, Ö., & Toprak, H. (2024). Updated endometrial cancer FIGO staging: the role of MRI in determining newly included histopathological criteria. Abdominal Radiology, 49(10), 3711-3721. https://doi.org/10.1007/s00261-024-04398-2

Vancouver

Akçay A, Gültekin MA, Altıntaş F, Peker AA, Balsak S, Atasoy B, et al. Updated endometrial cancer FIGO staging: the role of MRI in determining newly included histopathological criteria. Abdominal Radiology. 2024;49(10):3711-3721. doi:10.1007/s00261-024-04398-2

BibTeX
@article{Akay2024,
  author = {Akçay, Ahmet and Gültekin, Mehmet Ali and Altıntaş, Fazılhan and Peker, Abdusselim Adil and Balsak, Serdar and Atasoy, Bahar and Toluk, Özlem and Toprak, Hüseyin},
  title = {Updated endometrial cancer FIGO staging: the role of MRI in determining newly included histopathological criteria},
  journal = {Abdominal Radiology},
  year = {2024},
  volume = {49},
  number = {10},
  pages = {3711--3721},
  doi = {10.1007/s00261-024-04398-2}
}
Kostenlos starten →